Citation Impact
Citing Papers
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
2014
Patients with hippocampal amnesia cannot imagine new experiences
2007 StandoutNobel
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 Standout
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
2002 StandoutScience
Cochrane Database of Systematic Reviews
2003 Standout
Immunosuppressive Drugs: Azathioprine in the Treatment of Myasthenia Gravis
1987
Prevalence of Parkinson’s disease across North America
2018
A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity
1998 StandoutNobel
Lack of major olfactory dysfunction in MPTP‐induced parkinsonism
1992
How far are we in understanding the cause of Parkinson's disease?
1996
Long-term effects of exercise and physical therapy in people with Parkinson disease
2017
Osteoporosis
2019 Standout
Myasthenia Gravis
1988
Parkinson's disease
2021 Standout
Parkinson Disease in Twins
1999
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
1998 StandoutNature
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Genetics of Parkinson's disease
1997
Delirium in elderly people
2013 Standout
Fall events described by people with Parkinson's disease: implications for clinical interviewing and the research agenda
1999
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study
1998
Smoking and schizophrenia
1992
The circumstances of falls among people with Parkinson's disease and the use of Falls Diaries to facilitate reporting
2008
Interventions for preventing falls in older people living in the community
2009
Neuropsychiatric Adverse Effects of Antiparkinsonian Drugs
1997
Cognitive status correlates with neuropathologic stage in Parkinson disease
2005
Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease
2005
Deprenyl's effect at slowing progression of parkinsonian disability: the DATATOP study
1991
Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease
2005
Genetic aspects of Parkinson's disease
1998
Parkinson's disease
2009 Standout
Myasthenia Gravis
1994 Standout
The behavioral pharmacology of hallucinogens
2007
European consensus table 2006 on botulinum toxin for children with cerebral palsy
2006
Symmetrical body-weight distribution training in stroke patients and its effect on fall prevention
2001
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
Smoking and Mental Illness
2000 Standout
Diagnostic Criteria for Parkinson Disease
1999 Standout
Origin and functional consequences of the complex I defect in Parkinson's disease
1996
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
Parkinson's disease
2015 Standout
The Future of Memory: Remembering, Imagining, and the Brain
2012 StandoutNobel
The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α‐tocopherol
1997
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
2013
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism
2006
Effect of Constraint-Induced Movement Therapy on Upper Extremity Function 3 to 9 Months After Stroke
2006 Standout
Experiencing past and future personal events: Functional neuroimaging evidence on the neural bases of mental time travel
2007
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal
1994
Retrograde amnesia and memory consolidation: a neurobiological perspective
1995
Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease
2001
Recruitment to a clinical trial from the databases of specialists in Parkinson's disease
2006
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
SEMANTIC DEMENTIA
1992
Olfactory Testing as an Aid in the Diagnosis of Parkinson's Disease: Development of Optimal Discrimination Criteria
1995
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
1992
Parkinson's Disease
1998 Standout
Neuropathologic substrates of Parkinson disease dementia
2012
A large kindred with autosomal dominant Parkinson's disease
1990
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Lambert‐Eaton Myasthenic Syndrome
2003
Smoking and movement disorders in psychiatric patients
1991
Spatial Memory in the Rat Requires the Dorsolateral Band of the Entorhinal Cortex
2005 StandoutNobel
Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease
1995
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
2006
A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson's disease
2006
Amygdala pathology in Parkinson's disease
1994
Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa
2003
Nuclear and mitochondrial genetics in Parkinson's disease.
1995
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
1998
Mortality From Parkinson Disease
1997
Frailty in elderly people
2013 Standout
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
2017
Genetic Demonstration of a Role for PKA in the Late Phase of LTP and in Hippocampus-Based Long-Term Memory
1997 StandoutNobel
Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease
2001
The Brain's Default Network
2008 Standout
Parkinson's Disease
2003 Standout
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
Abnormalities of the electron transport chain in idiopathic parkinson's disease
1989
IgG from Patients with Lambert-Eaton Syndrome Blocks Voltage-Dependent Calcium Channels
1988 StandoutScienceNobel
Cigarette smoking and protection from Parkinson's disease
1995
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Memory--a Century of Consolidation
2000 StandoutScience
Smoking and Parkinson's Disease
1986
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
PLASMA EXCHANGE ALONE AS THERAPY FOR MY ASTHENIA GRAVIS*
1981
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
1992 Standout
THE EFFECT OF A HOME PHYSIOTHERAPY PROGRAM FOR PERSONS WITH PARKINSON'S DISEASE
2001
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
1988 Standout
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
1997 StandoutScience
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Role of left inferior prefrontal cortex in retrieval of semantic knowledge: A reevaluation
1997 Standout
Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.
1980
Reasons for Variability in the Reported Rate of Occurrence of Unilateral Spatial Neglect After Stroke
1999 Standout
Epidemiology of Parkinson’s Disease
1992
Nerve Cell Death in Degenerative Diseases of the Central Nervous System: Clinical Aspects
2007
Update on Parkinson Disease
2003
AETIOLOGY OF PARKINSON'S DISEASE
1983
Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
1984 StandoutScience
Apolipoprotein E controls the risk and age at onset of Parkinson disease
2004
EPIDEMIOLOGY OF PARKINSON'S DISEASE
1996
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
2004 StandoutScience
The role of environmental toxins in the etiology of Parkinson's disease
1989
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
2000
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
2005
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Management of Adult Stroke Rehabilitation Care
2005
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 StandoutScience
Interventions for preventing falls in older people living in the community
2012 Standout
Spatial Representation in the Entorhinal Cortex
2004 StandoutScienceNobel
Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's disease and their carers
2002
Retrograde Amnesia for Spatial Memory Induced by NMDA Receptor-Mediated Long-Term Potentiation
2001 StandoutNobel
Smoking and Parkinson's disease: a case-control study in Germany
1997
Mortality in DATATOP: A Multicenter trial in early Parkinson's disease
1998
Works of Christopher D. Ward being referenced
Parkinson's disease in twins.
1984
Education for people with progressive neurological conditions can have negative effects: Evidence from a randomized controlled trial
2004
OBSERVATIONS DURING TRANSIENT GLOBAL AMNESIA
1989
Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy
2002
Double‐blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy
2002
Research diagnostic criteria for Parkinson's disease.
1990
Olfactory impairment in Parkinson's disease
1983
LONG-TERM EFFECTS OF REPEATED PLASMA EXCHANGE IN MYASTHENIA GRAVIS
1979
Rehabilitation in Parkinson's disease
1992
Predicting Fallers in a Community-Based Sample of People with Parkinson’s Disease
2001
The contribution of amphetamine metabolites of (?)-deprenyl to its antiparkinsonian properties
1982
Effect of temperature on neuromuscular transmission in the Eaton-Lambert syndrome
1979
Asymmetrical trunk posture, unilateral neglect and motor performance following stroke
1994
Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.
1994
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
1983
Methods for evaluating treatment in Parkinson's disease.
1983
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke
2000
Comparison of pergolide and bromocriptine therapy in parkinsonism
1983
Lisuride versus bromocriptine treatment in Parkinson disease
1982
Lisuride in parkinsonism
1981